Sharemaestro Newsreel

Earnings call transcript: Sanuwave Health misses Q2 2026 estimates as sales slide

Sanuwave Health reported a wider-than-expected loss and missed revenue estimates for Q2 2026, primarily due to a sharp decline in UltraMIST system sales, despite growth in recurring applicator revenue. The company withdrew its full-year 2026 revenue guidance, citing uncertainty surrounding potential Medicare reimbursement changes …

SANUWAVE Health, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:SNWV) 2026-08-07

This article provides details on SANUWAVE Health, Inc.'s Q2 2026 earnings call presentation. The company published a slide deck in conjunction with the call, which is the subject of this content. The article was written by SA Transcripts, a team responsible for publishing numerous …

Royal Bank of Canada Decreases Stake in UFP Technologies, Inc. $UFPT

Royal Bank of Canada reduced its stake in UFP Technologies (NASDAQ:UFPT) by 12.5% in the first quarter, selling 11,343 shares and retaining 79,179 shares valued at $15.3 million. Despite this, UFP Technologies reported strong quarterly earnings of $2.92 EPS and revenue of $173.96 million, …

Janus Henderson Group PLC Has $3.76 Million Stock Holdings in UFP Technologies, Inc. $UFPT

Janus Henderson Group PLC significantly reduced its stake in UFP Technologies, Inc. (NASDAQ:UFPT) by 75.5% in the first quarter, now holding 19,436 shares valued at $3.76 million. Despite this, other institutional investors have increased their holdings, with institutional investors collectively owning 87.28% of the …

MaxCyte (MXCT) Q1 2026 Earnings: Narrower Loss Beats Estimates as Shares Rise 6.31% - Revenue Estimate Trend

DexCom, Inc. $DXCM Shares Sold by Pacer Advisors Inc.

Pacer Advisors Inc. significantly reduced its stake in DexCom (NASDAQ:DXCM) by 96.5% in the first quarter, selling 948,754 shares and retaining 34,025 shares. Despite this, institutional investors and hedge funds still own 97.75% of the company, and analyst sentiment remains positive with a "Moderate …

Integra LifeSciences Holdings Corporation (IART) Interactive Stock Chart

PAVM Q2'26 Earnings: revenue estimate is 48.00K USD

PAVmed Inc. (PAVM) is scheduled to release its Q2'26 earnings on August 14th, with an expected revenue estimate of $48.00 thousand USD and an anticipated EPS of ($0.47). The article also provides a table comparing reported and estimated revenues and EPS from Q2'25 through …

Novocure Ltd (NVCR) Stock Analysis & Forecast

Novocure Ltd (NVCR) saw its stock surge to $19.91 following stronger-than-expected Q2 2026 earnings. The company reported revenue that exceeded consensus estimates, growing 8.6% year-over-year. This recovery is primarily attributed to the FDA approval and multi-indication expansion of its Optune Pax treatment, especially after …

Treace Medical Concepts: Q2 Earnings Snapshot

Treace Medical Concepts Inc. (TMCI) reported a second-quarter loss of $15.9 million, equating to 24 cents per share. The orthopedic medical device maker generated $45.4 million in revenue for the period and expects full-year revenue to be between $204 million and $212 million. This …

Koninklijke Philips N.V. $PHG Position Raised by Royal Bank of Canada

Royal Bank of Canada increased its stake in Koninklijke Philips N.V. (PHG) by 13.1% in the first quarter, now holding shares valued at approximately $13.6 million. Despite institutional interest, analyst sentiment remains cautious, with a consensus "Reduce" rating for the stock. Philips recently exceeded …

Royal Bank of Canada Decreases Holdings in Penumbra, Inc. $PEN

Royal Bank of Canada significantly reduced its stake in Penumbra, Inc. by nearly 50% in the first quarter, selling 39,656 shares and retaining 39,794 shares valued at $13.1 million. This comes as Penumbra reported mixed financial results, with revenue slightly above estimates but EPS …

Why Did TNDM Stock Jump 5% After Hours Despite Q4 Earnings Miss?

Co-Diagnostics Submits Co-Dx PCR Flu A/B & RSV Test for FDA Clearance

Co-Diagnostics has submitted its Co-Dx PCR Flu A/B & RSV multiplex respiratory test for FDA clearance, including a dual 510(k) premarket notification and a CLIA Waiver by Application. This submission is backed by extensive clinical studies involving over 1,400 patients and an analytical program …

Alamar Biosciences Inc expected to post a loss of 33 cents a share - Earnings Preview

Alamar Biosciences Inc is projected to report a loss of 33 cents per share, according to this earnings preview. The article, sourced from Reuters via Refinitiv, provides an outlook on the company's upcoming financial performance.

NeuroPace, Inc. expected to post a loss of 21 cents a share - Earnings Preview

NeuroPace, Inc. is projected to report a loss of 21 cents per share, according to this earnings preview. The article indicates that this financial outlook is based on information from Refinitiv. Full article access requires a TradingView subscription.

Butterfly Network (BFLY) Is Up 24.2% After Raising 2026 Guidance And Narrowing Losses - Has The Bull Case Changed?

SINTX Technologies Inc (SINT) Stock News Today

This page from TradingKey provides current stock news for SINTX Technologies Inc (SINT). It displays the latest stock price, market cap, and offers links to detailed financial information, stock scores, technical analysis, and ownership data. The article notes that more news is coming soon …

Czech National Bank Acquires 16,292 Shares of Medtronic PLC $MDT

The Czech National Bank increased its stake in Medtronic PLC (NYSE:MDT) by 4.7% in the second quarter, purchasing an additional 16,292 shares, bringing its total holdings to 365,443 shares valued at approximately $28.6 million. Medtronic recently exceeded quarterly earnings expectations, reporting $1.55 in adjusted …

Beacon Investment Advisory Services Inc. Has $9.03 Million Stock Holdings in Insulet Corporation $PODD

Beacon Investment Advisory Services Inc. reduced its stake in Insulet Corporation (NASDAQ:PODD) by 13.3% in the second quarter, now holding 59,333 shares valued at approximately $9.03 million. Despite Insulet reporting strong second-quarter revenues and adjusted EPS that beat analyst expectations, the company lowered its …

Levi & Korsinsky Notifies RxSight, Inc. (RXST) Investors - Lead Plaintiff Deadline on September 22, 2025

Levi & Korsinsky LLP has announced a lead plaintiff deadline of September 22, 2025, for investors of RxSight, Inc. (RXST) who suffered losses. The class action securities lawsuit alleges that RxSight made false statements regarding "adoption challenges," overstated product demand, and was unlikely to …

CVRx, Inc. (NASDAQ:CVRX) Given Consensus Recommendation of "Hold" by Brokerages

CVRx, Inc. (NASDAQ:CVRX) has received a consensus "Hold" recommendation from six brokerages, with an average 12-month price target of $6.90. The company's stock recently fell significantly to $2.72 after reporting a $0.53-per-share quarterly loss and negative net margin, despite beating revenue expectations. Analysts have …

Lumexa Imaging (NASDAQ:LMRI) Stock Rating Lowered by Wall Street Zen

Wall Street Zen has downgraded Lumexa Imaging (NASDAQ:LMRI) from a "buy" to a "hold" rating, despite the broader analyst consensus remaining a "Moderate Buy" with a $16.00 price target. Lumexa shares opened at $11.58, and institutional investors like BlackRock Inc. have recently increased their …

QT Imaging Holdings Inc (QTI) Stock News Today

This article provides an overview of QT Imaging Holdings Inc (QTI) stock news. It states that more news is coming soon, and highlights current stock information including its price, market cap, and links to various financial data sections on the TradingKey platform.

CytoSorbents Reports Second Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update

CytoSorbents Corporation reported its Q2 2026 financial results, with revenue unchanged at $9.6 million but an improved gross margin of 73%. The company reduced its operating loss by 27% and adjusted EBITDA loss by 38%, aiming for operating cash flow breakeven in the second …

Haemonetics (NYSE:HAE) Upgraded by Wall Street Zen to Strong-Buy Rating

Wall Street Zen has upgraded Haemonetics (NYSE:HAE) to a "strong-buy" rating, reflecting positive analyst sentiment and strong financial performance. The company exceeded quarterly expectations with $1.14 EPS and $339.38 million in revenue, leading management to raise its fiscal 2027 revenue-growth outlook to 5%-8%. Haemonetics' …

UBS Maintains Steris PLC(STE.US) With Buy Rating, Cuts Target Price to $270

UBS has reiterated its Buy rating for Steris PLC (STE.US) but has reduced the target price for the company's stock to $270. This adjustment reflects a continued positive outlook on Steris PLC despite a revised valuation.

Inogen Inc Q2 2026: Revenue $95.08M, EPS $(0.14) — 10-Q Summary

Inogen Inc. reported Q2 2026 revenue of $95.08M and diluted EPS of $(0.14), marking modest top-line growth and improved margins. The company's net loss narrowed to $3.85M from $4.15M a year prior, driven by higher unit volumes and favorable foreign exchange, particularly in international …

Icecure Medical Ltd (ICCM) News, Articles, Events & Latest Updates

IceCure Medical (ICCM) is actively expanding its clinical studies and commercial reach for its ProSense cryoablation technology. The company recently added Adventist Health as a U.S. clinical site for its "ChoICE" study for low-risk breast cancer and will report its first-half 2026 financial results …

Elutia Inc. (ELUT) Files Form 8-K: Nasdaq-Listed Delaware Biologics Company Updates Corporate Information

Elutia, Inc. (ELUT) has filed a Form 8-K disclosing that it received a notice from Nasdaq regarding non-compliance with the minimum bid price requirement. This places the company's Nasdaq listing at risk, and it must regain compliance within a defined period to avoid delisting. …

Nortech Systems Inc (NSYS) Stock News Today

This article provides the current stock information for Nortech Systems Inc (NSYS), including its latest stock price, market cap, and P/E ratio. It indicates that more news will be available soon and encourages users to stay tuned for updates on earnings, analyst ratings, and …

Nexalin Technology Inc (NXL) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Nexalin Technology Inc (NXL), detailing its current earnings forecast score, average price target, and analyst rating. Based on one analyst, the company has a "Buy" rating with a target price indicating significant upside potential. Key financial forecasts …

PODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit with SBS Law

Schall, Brown & Schwartz LLP (SBS) is reminding investors of a class action lawsuit against Insulet Corporation (NASDAQ: PODD) for alleged securities fraud. The lawsuit claims Insulet made false statements regarding defective manufacturing controls, increased safety violation risks, and the scope of a Medical …

Delcath Systems (DCTH) Stock Profit Turn Faces Pricing Pressure

Sight Sciences (NASDAQ:SGHT) Rating Increased to Buy at Wall Street Zen

iRhythm Technologies (NASDAQ:IRTC) Rating Lowered to "Hold" at Wall Street Zen

Wall Street Zen has downgraded iRhythm Technologies (NASDAQ:IRTC) to a "Hold" rating from "Buy," despite the company's strong Q2 results and a broader analyst consensus of "Moderate Buy." iRhythm reported earnings of $0.58 per share against an expected loss and saw revenue increase by …